Stratasys Introduces BioMimics – Highly Realistic, 3D Printed Models of Human Anatomy for Physician Training and Medical Device Testing

• Unveiled at RSNA 2017, 3D printed anatomical structures with disease
  pathology deliver highly realistic look and feel to accelerate medical
  guidance, testing, and education
• Engineered in conjunction with top researchers and manufacturers,
  service initially includes fully-functional bone and heart models –
  with vascular structures expected in early 2018
• Eliminating restrictions associated with research on animal,
  mannequin, or cadaver models – BioMimics effectively mirrors
  intricacies of both soft tissue and hard bones via multi-material 3D
  printing
• Available now in North America through Stratasys Direct Manufacturing,
  see BioMimics in action at RSNA 2017 – North Hall B, #7565

MINNEAPOLIS & REHOVOT, Israel–(BUSINESS WIRE)–Stratasys
(NASDAQ: SSYS), a global leader in applied additive technology
solutions, today unveiled BioMimics – a highly advanced capability to 3D
print medical models that are engineered to meet demands of the
industry’s leading hospitals, researchers and medical device
manufacturers. Offered initially in North America as a service through
Stratasys Direct Manufacturing, BioMimics provides incredibly realistic,
functionally-accurate 3D printed replicas of complex anatomical
structures – empowering more effective medical training, education and
advanced device testing.

Eliminating restrictions associated with training, research and testing
on animal, mannequin, or cadaver models – BioMimics effectively mirrors
the intricacies of both soft tissue and hard bones via multi-material 3D
printing. Combining Stratasys’ proven PolyJet 3D printing technology
alongside new materials and software, organizations can create specific
3D printed models that match what professionals encounter during live
medical scenarios. Additionally, OEMs can gain real-time feedback on
device performance in realistic environments – prior to actual
deployment.

“Testing innovative medical devices, teaching principles of surgery,
providing continuing medical education, and demonstrating new products
to clinicians all require ‘bench-top’ models that simulate human bodies
and diseases. Much like simulation and co-piloting builds expertise for
pilots, medical practitioners hone skills throughout their careers to
provide exceptional care,” said Scott Rader, GM of Healthcare Solutions
at Stratasys. “The challenges of today’s solutions include animal models
that only approximate human anatomy, and cadavers that don’t retain the
live-tissue feel and often lack targeted pathology.”

Rader continued, “BioMimics is a revolution in medical modeling,
capitalizing on advanced 3D printing techniques for clinically accurate
representations of complex human anatomies – from microscopic patterns
of tissue to replicating soft to hard texture of body structures. Armed
with unmatched realism of BioMimics, researchers, educators and
manufacturers can finally utilize the tools to prove out new ideas long
before clinical trials, and demonstrate innovations to the skilled
physicians who rely on them.”

Available today in North America through Stratasys Direct Manufacturing,
BioMimics is initially designed to model the complexities of heart and
bone structures – with vascular anatomies expected in early 2018.
Engineered alongside the industry’s top researchers and manufacturers,
the service empowers customers to either capitalize on a variety of
existing BioMimics models, or design enhanced anatomical structures that
match distinct clinical requirements.

“The Jacobs Institute has been using Stratasys 3D printing solutions to
replicate vascular anatomy for many years. The BioMimics capabilities
Stratasys has now developed enable a level of biomechanical realism and
clinical sophistication not previously available in any vascular model.”
said Dr. Adnan Siddiqui, Chief Medical Officer at Jacobs Institute,
Vice-Chairman and Professor of Neurosurgery at University of Buffalo
Neurosurgery. “BioMimics will enhance medical innovation in vascular
disease by enabling improved pre-clinical validation of new devices and
clinically realistic training simulators.”

“As one of the top research and pediatrics hospitals in Canada, SickKids
is committed to unprecedented innovation to positively impact the
well-being of children around the world. We have developed new training
programs through 3D printing that allow surgeons to practice procedures
on replicas of real patient’s pathology,” said Shi-Joon Yoo, MD, PhD,
Cardiac Radiologist at the Hospital for Sick Children and Professor of
Medical Imaging and Pediatrics at University of Toronto. “BioMimics
enhances the realism and clinical validity of the models even further –
allowing the surgeons to develop the techniques and skills that will
translate into live patient cases.”

BioMimics is being demonstrated for the first time at RSNA 2017 – the 103rd
Scientific Assembly and Annual Meeting of the Radiological Society of
North America. Stop by Stratasys’ booth – North Hall B, No. 7565 – to
see BioMimics in action.

Available Multimedia Assets

Video:
Case Study at Hospital for Sick Children

Video:
Using BioMimics for Surgical Planning

BioMimics
web page, including:

• Written case study
• BioMimics Brochures

About Stratasys Direct Inc.

Stratasys Direct Inc. is an indirect subsidiary of Stratasys Ltd.
Stratasys Direct Manufacturing is a leading provider of 3D printing and
advanced manufacturing services utilizing the latest technologies and
decades of experience. With a broad range of additive and conventional
manufacturing services, Stratasys Direct Manufacturing assists companies
at all stages of product development to bring better products to the
market faster. Stratasys Direct Manufacturing has more than 500
employees across seven manufacturing facilities in the United States.
Online at: www.stratasysdirect.com.

About Stratasys

Stratasys (NASDAQ: SSYS) is a global leader in applied additive
technology solutions for industries including Aerospace, Automotive,
Healthcare, Consumer Products and Education. For nearly 30 years, a deep
and ongoing focus on customers’ business requirements has fueled
purposeful innovations—1,200 granted and pending additive technology
patents to date—that create new value across product lifecycle
processes, from design prototypes to manufacturing tools and final
production parts. The Stratasys 3D printing ecosystem of solutions and
expertise—advanced materials; software with voxel level control;
precise, repeatable and reliable FDM and PolyJet 3D printers;
application-based expert services; on-demand parts and industry-defining
partnerships—works to ensure seamless integration into each customer’s
evolving workflow. Fulfilling the real-world potential of additive,
Stratasys delivers breakthrough industry-specific applications that
accelerate business processes, optimize value chains and drive business
performance improvements for thousands of future-ready leaders around
the world.

Corporate Headquarters: Minneapolis, Minnesota and Rehovot, Israel.

Online at: www.stratasys.com,
http://blog.stratasys.com and
LinkedIn.

Stratasys is a registered trademark and PolyJet and Stratasys signet
are trademarks or registered trademarks of Stratasys Ltd. and or its
subsidiaries or affiliates. All other trademarks belong to their
respective owners.

Attention Editors, if you publish reader-contact information, please use:

• USA 1-877-489-9449
• Europe/Middle East/Africa +49-7229-7772-0
• Asia Pacific +852 3944-8888

Contacts

Stratasys
Arita Mattsoff, +972 74 745 4000 (IL)
[email protected]
Joe
Hiemenz, +1 952 906 2726 (US)
[email protected]
or
North
America
Stratasys
Craig Librett, +1 518 424 2497
[email protected]
or
Europe
Incus
Media
Jonathan Wake / Miguel Afonso, +44 1737 215200
[email protected]
or
Greater
China, Southeast Asia, ANZ, and India
Alison Yin,
+86-21-33196051
[email protected]
or
Japan
and Korea
Stratasys Japan
Aya Yoshizawa, +81 90 6473 1812
[email protected]
or
Mexico,
Central America, Caribe and South America
Stratasys Mexico
Yair
Canedo, +52 55 4169 4181
[email protected]
or
Brazil
GPCOM
Clezia
Martins Gomes, +55 (11) 3129 5158
[email protected]